Business Wire

Quidel Opens New Manufacturing Facility to Mass Produce QuickVue® Rapid Antigen Tests for COVID-19

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Business Wire

Quidel’s Sofia® SARS Antigen Test Receives Emergency Use Authorization for Screening Use With Serial Testing

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Nasdaq

Quidel Receives Amended Emergency Use Authorization for New Sofia® Q Rapid Antigen Test Device

Quidel plans initial release to professional and point-of-care segments with a goal of expansion to serve telemedicine and home markets Sofia Q is the latest product in Quidel’s best-selling Sofia ...
Reuters

U.S. FDA grants emergency use authorization to Quidel for first antigen test for COVID-19

(Reuters) - The U.S. Food and Drug Administration (FDA) on Saturday approved emergency use authorization (EUA) to Quidel Corp for the first COVID-19 antigen test. The emergency use authorization was ...
BioWorld

Quidel wins first non-EUA COVID test authorization for Sofia rapid antigen test

The FDA’s emergency use authorization (EUA) program for rapid antigen tests for the COVID-19 pandemic is coming to an end, but few rapid antigen test makers have laid out clear plans regarding the ...
AOL

Quidel issued first emergency use authorization by FDA for a COVID-19 antigen test

Doug Bryan, Quidel CEO, joins Yahoo Finance’s Anjalee Khemlani, Alexis Christoforous, and Kristin Myers to discuss the company’s outlook. KRISTIN MYERS: Welcome back. Quidel was given an emergency use ...